HUM vs LPCN · P/E 39, rev $129.66B vs rev $11.2M
Humana Inc (HUM) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported LPCN revenue for 2024-12-31 was $11.2M. Net income was $8.4K. Revenue was up 492.8% from 2023-12-31 to 2024-12-31. LPCN currently screens at market cap $19.3M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. LPCN currently screens at market cap $19.3M.
Not investment advice. Open the HUM and LPCN stock pages for the full models.
Not investment advice.